Actor Berto Colón Joins Cristian Rivera Foundation's Board to Support Pediatric Brain Tumor Research

Berto Colón Joins the Cristian Rivera Foundation Board

The Cristian Rivera Foundation (CRF) is excited to welcome actor Berto Colón to its board, a move that signifies a reinforced commitment to fighting Diffuse Intrinsic Pontine Glioma (DIPG), a rare and aggressive pediatric brain tumor. John "Gungie" Rivera, the founder of the foundation, expressed his enthusiasm, stating that Colón's determination aligns seamlessly with the foundation's mission.

Colón, known for his roles in popular series such as Orange is the New Black, The Penguin, and Power Book II: Ghost, sees this collaboration as a chance to make a meaningful impact. His latest work, in Night Agent Season 2, which premiered on Netflix, has already garnered significant attention globally.

A Personal Connection to the Cause

Reflecting on his motivations, Colón shared, "One can only marvel at the strength and commitment of John 'Gungie' Rivera to carry on his son Cristian's legacy. His dedication to finding a cure for DIPG, the disease that claimed his son, is deeply admirable. Growing up in the Bronx, I was unaware of his heartbreaking loss until we reconnected later in life. That experience sparked a desire in me to join in his mission and help prevent other families from enduring similar tragedies. As a father and husband, the idea of such loss is unimaginable."

Colón's heartfelt words underscore the urgency and importance of the foundation's work. The Cristian Rivera Foundation is striving to create a world free of DIPG and aims to amplify awareness, fund research, and support affected families.

Leadership and Vision

Chairwoman Melinda Colon Cox praised Colón for his passion and dedication, pointing out that the board seeks individuals who are genuinely committed to making a difference. Colón joins other distinguished members on the board, including notable figures like Kenan Thompson and actor Malik Yoba.

Since its establishment in 2009, the Cristian Rivera Foundation has invested over 3.5 million dollars into groundbreaking research and family support initiatives. This funding has led to significant advances, including promising clinical trial results at Weill Cornell Medical Center. Additionally, the foundation has collaborated in genetic research aimed at finding solutions that might one day save countless lives.

Ongoing Efforts and Community Impact

The foundation continues to be proactive in its mission through various initiatives. These include fundraising events, newsletters, and extensive media campaigns aimed at illuminating the widespread impact of DIPG on children and families. Furthermore, CRF serves as a critical resource, offering assistance and support to families navigating the challenges posed by this devastating illness.

Colón’s involvement is seen as an invigorating force within the foundation as it pushes forward in its fight against DIPG. The combination of his public platform and genuine commitment is expected to elevate the ongoing efforts to create a brighter future for children battling this harsh disease. The foundation believes that with increased awareness and significant funding, strides can be made towards finding a cure.

In summary, Berto Colón's appointment to the Cristian Rivera Foundation illustrates a unified front in the fight against DIPG. Together, they aim to bring hope and support to families while making tangible progress in medical research. This collaboration symbolizes a broader movement towards creating a world where children impacted by DIPG can dream big and live without fear.